title: Can mesorectal lymph node excision be avoided in rectal cancer surgery?
abstract: Rectal excision is the standard in rectal cancer treatment. The morbidity of rectal excision, together with the low rate of positive lymph nodes in patients with a good response after radiochemotherapy, raises the challenging concept of organ preservation. Patients with a complete response can benefit from a nonoperative strategy based on a strict follow up. Those with a complete or subcomplete response can be treated by local excision. Limitations in accurately assessing a complete response by conventional and modern imaging modalities suggest that local excision is more appropriate for the majority of patients when organ preservation is being considered. The encouraging results of retrospective series of local excision in downstaged clinical T2/T3 low rectal cancer after radiochemotherapy, however, need to be confirmed by the ongoing multicentre phase II United States and phase III French trials before routinely proposing organ preservation in patients with a good response.
authors.affiliation: Department of Surgery, Saint-Andre Hospital, Victor Segalen University of Bordeaux, Bordeaux, France. eric.rullier@chu-bordeaux.fr
authors.forename: E
authors.initials: E
authors.lastname: Rullier
authors.forename: V
authors.initials: V
authors.lastname: Vendrely
mesh_terms: D002277:Carcinoma / Q000473:pathology* / Q000628:therapy*; D059248:Chemoradiotherapy; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology / Q000601:surgery; D008207:Lymphatic Metastasis; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D059351:Organ Sparing Treatments; D012004:Rectal Neoplasms / Q000473:pathology* / Q000628:therapy*; D016896:Treatment Outcome; D057832:Watchful Waiting